US2020087715A1PendingUtilityA1

Selective oxidation of 5-methylcytosine by tet-family proteins

Assignee: CHILDRENS MEDICAL CENTERPriority: Sep 26, 2008Filed: Nov 21, 2019Published: Mar 19, 2020
Est. expirySep 26, 2028(~2.2 yrs left)· nominal 20-yr term from priority
C12Q 2521/531G01N 33/5308C12Q 2522/10C12Q 1/26C12N 2501/70C12N 2501/71C12Q 2537/164G01N 33/5011C12Q 1/6806G01N 2500/00C12Q 2600/154C12Q 1/6869C12Q 1/6827C12N 9/0071C12N 5/0637C12N 2501/604C12N 2506/1353C12N 2501/999C12N 2501/603C12N 5/0018C12N 2501/606C12N 2510/00C12N 2501/15C12Q 1/6886C12N 5/0696C12N 5/0607G01N 33/57484G01N 33/57496C12N 2501/602G01N 33/57426C12N 15/873C12N 2506/1307C12N 2501/724C12N 9/1007
85
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TET3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.

Claims

exact text as granted — not AI-modified
1 .- 10 . (canceled) 
     
     
         11 . A method comprising:
 high throughput sequencing a nucleic acid sequence; and   detecting a methylation state of a site in said nucleic acid sequence, wherein said nucleic acid sequence comprises a hydroxymethylated base.   
     
     
         12 . The method of  claim 11 , wherein said nucleic acid sequence is a mammalian nucleic acid sequence. 
     
     
         13 . The method of  claim 11 , wherein said nucleic acid sequence is obtained from a eukaryotic organism 
     
     
         14 . The method of  claim 11 , wherein said nucleic acid sequence is not obtained from a bacteriophage. 
     
     
         15 . The method of  claim 11 , wherein said nucleic acid sequence is of an extracellular fluid sample. 
     
     
         16 . The method of  claim 11 , further comprising isolating said nucleic acid sequence from a sample. 
     
     
         17 . The method of  claim 11 , further comprising obtaining said nucleic acid sequence. 
     
     
         18 . The method of  claim 11 , further comprising associating a label with said site. 
     
     
         19 . The method of  claim 11 , wherein said site comprises a genomic region. 
     
     
         20 . The method of  claim 11 , wherein said nucleic acid sequence is from a subject in need thereof. 
     
     
         21 . The method of  claim 11 , wherein said nucleic acid sequence is from a subject having or suspected of having cancer.

Join the waitlist — get patent alerts

Track US2020087715A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.